Boron – What Is It?

Boron is one of many ingredients in the Tikva product. It is a biologically dynamic ultra trace element important in human metabolism.

Studies demonstrate its involvement in several processes, especially macromineral metabolism. Studies show that it is a metabolic regulator and plays an important role in cell membrane function. Recent studies suggest that boron is important for calcium utilization in the body. In human deficiency studies, supplementation improved several parameters including mental alertness, memory, Mineral metabolism, and blood Hemoglobin.

–WholeHealthMD

Boron Health Benefits

Osteoporosis And Arthritis

This trace mineral is now an interesting nutritional topic in medical literature. Preliminary results indicate this important nutrient may be helpful in maintaining healthy bone and joint function.

It appears to reduce body calcium loss by increasing the beneficial effects of estrogen on bone health.

Boron deficiency may contribute greatly to the high rate of osteoporosis and menopausal symptoms in American women.

Boron supplementation has been used in the treatment of osteoarthritis in Germany since the mid 1970’s. This use was recently evaluated in a small double blind clinical trial and an open trial. In the double blind study of the patients given 6 mg of boron, 71% improved compare to only 10% in the placebo group. In the open trial, supplementation produced effective relief in 90% of arthritis patients. The preliminary indication is that supplements are valuable in arthritis, and many people with osteoarthritis experience complete resolution.

Individuals at risk for osteoporosis should supplement with 3-9 mg of boron daily.

-Encyclopedia of Nutritional Supplements. 1996

Osteoarthritis

A clinical trial involved 20 patients with radiographically confirmed osteoarthritis. This was a double blind, placebo-controlled study in which half of the subjects were given 6mg of boron daily while the other half received the placebo. The subjects were evaluated three times – prior to taking the tablets, after three weeks on the tablets and after eight weeks on the tablets. Patients were graded with respect to their symptoms as well as their use of a permitted analgesic. At the end of the eight-week period, 50% of those taking it showed improvement, while only 10% of those on placebo showed similar improvement. The finding was declared statistically significant.

-PDR (Physicians Desk Reference -2001)

Share this article with someone you care about
by clicking one of the sharing buttons below.